Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ARISAN THERAPEUTICS INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-09-28 to 2023-09-27
Current total value of award: $269361.72
Description: SBIR PHASE II FOR RESEARCH ON EFFICACY OF ARN-75039 AGAINST LASSA VIRUS.